Ingenia, Ingenia CX, Ingenia Elition, Ingenia Ambition, MR 5300 and MR 7700 MR Systems

The Philips MR systems, including Ingenia and MR 7700 series, utilize magnetic resonance principles to generate detailed diagnostic images and support interventional guidance, with the core science involving the analysis of relaxation signals from atomic nuclei in a magnetic field. The introduction of the 'Precise Image' software feature, a deep learning-based reconstruction technique, significantly enhances image quality by improving SNR and sharpness and reducing artifacts, as demonstrated in non-clinical studies.

The Philips Ingenia, Ingenia CX, Ingenia Elition, Ingenia Ambition, MR 5300, and MR 7700 MR Systems are medical electrical systems designed for use as diagnostic devices. They enable trained physicians to obtain cross-sectional images, spectroscopic images, and spectra of the internal structures of the head, body, or extremities. These images, which represent the spatial distribution of protons or other nuclei with spin, are influenced by tissue properties, scan techniques, and contrast agents, providing information to assist in diagnosis and therapy planning. The systems also offer MR fluoroscopy capabilities to guide and evaluate interventional and minimally invasive procedures. A key modification in these systems is the introduction of an optional software feature named 'Precise Image,' a deep learning-based reconstruction technique. This innovation is engineered to enhance MR image quality by increasing the signal-to-noise ratio (SNR), improving image sharpness, and reducing ringing artifacts. Non-clinical performance evaluations, including simulated use validation and reader studies by board-certified radiologists, indicated that 'Precise Image' produces images diagnostically equivalent to predicate technologies but with significantly better SNR and sharpness, even in the presence of subtle abnormalities or pathologies.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the 'Precise Image' deep learning algorithm differentiate between true anatomical detail and noise or artifacts during the reconstruction process across various tissue types?; What specific quantitative improvements in signal-to-noise ratio and image sharpness were observed with 'Precise Image' compared to previous reconstruction techniques across different field strengths (1.5T and 3.0T)?; Are there particular MR sequences or clinical applications (e.g., neurological, musculoskeletal, abdominal imaging) where the benefits of 'Precise Image' are most pronounced?; What is the computational overhead or increase in image reconstruction time associated with using the 'Precise Image' feature, and how might this impact clinical workflow?; How was the 'Precise Image' deep learning model trained, and what measures are in place to ensure its generalizability and robustness across diverse patient populations and pathologies not extensively covered in the training data?